No Result
View All Result
SUBSCRIBE | NO FEES, NO PAYWALLS
MANAGE MY SUBSCRIPTION
NEWSLETTER
Corporate Compliance Insights
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Career Connection
  • Events
    • Calendar
    • Submit an Event
  • Library
    • Whitepapers & Reports
    • eBooks
    • CCI Press & Compliance Bookshelf
  • Podcasts
  • Videos
  • Subscribe
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Career Connection
  • Events
    • Calendar
    • Submit an Event
  • Library
    • Whitepapers & Reports
    • eBooks
    • CCI Press & Compliance Bookshelf
  • Podcasts
  • Videos
  • Subscribe
No Result
View All Result
Corporate Compliance Insights
Home Compliance

Medical Device Loans: Transparency is Key to Anti-Corruption

by Wendy Wysong
June 25, 2015
in Compliance
Medical Device Loans: Transparency is Key to Anti-Corruption

with contributing authors Yu Bing and Shi Lei

Medical device firms have long been targets of anti-bribery investigations in China. Many of them have designed and implemented stringent compliance policies to prevent typical corruption conducts such as kickbacks and luxurious entertainments. However, this does not remove them from regulators’ attention; in recent years, many medical device firms are facing investigations on business activities that are not traditionally seen as bribery. One example is the rental-free equipment loan arrangement.

Business Model

Equipment loans are common in the medical device industry because hospitals are often unwilling or incapable of paying the full price for or even renting the device at a market rate, so a medical device firm may offer an option of obtaining the loan of equipment for free or at a heavily discounted rate, provided that the hospitals hit certain annual supply and purchase targets. This business model has often been used to promote newly developed devices or to encourage hospitals to purchase more consumables associated with the loaned equipment.

Some medical device firms have recently become alert to the risks of directly leasing equipment to hospitals for free. In order to keep a clear record on their own books, they instead lease the equipment to distributors at the fair market rental value, leaving it to the distributors’ discretion whether to exempt hospitals from paying rent. Predictably, distributors often have incentives to provide a rental-free loan arrangement to hospitals.

Legal Risks

On the face of it, this business model may appear to be justifiable. The benefits are given to the hospital, instead of any individuals making the purchase decisions for or on behalf of the hospital. Further, this arrangement is usually not entirely under the table, but is reflected in contracts or the medical device firms’ sales and reward policies.

Despite these justifications, this arrangement has been challenged by local regulators, and in particular, the local primary regulators of commercial bribery, China’s Administration for Industry and Commerce (AIC).  In the AIC’s view, the benefits of the equipment loans are not and cannot be accurately reflected in books and records. The AIC further asserts that as no rent has been paid, hospitals are able to evade tax liabilities for the benefit of using the loaned equipment; they reason that medical device firms are effectively facilitating such tax evasion, which is an illegitimate benefit, or a bribe, in their view. Interestingly, this point is often made not by tax authorities, but by the AIC.

In addition, it is not uncommon for the medical device firm to tie this rental-free arrangement to sales of its own consumables. Depending on the medical device firm’s market share, this has been viewed as a bundling arrangement and thus, raises exposure to anti-trust investigations. The risk is further enhanced if this tie-in arrangement is exclusive (i.e., when only the same firm’s consumables can be used in its loaned equipment).

The practice of granting the loan through distributors is not risk free either. Local regulators may find, despite the indirect transaction, evidence or inferences that a medical device firm is or should be aware of the rental-free equipment loan arrangement between its distributors and end users (i.e., hospitals). If so, they will conclude that the medical device firm is part of a conspiracy. Under the U.S. Foreign Corrupt Practices Act (FCPA), absence of actual knowledge under these circumstances may not provide a valid defense, as this may be seen as a conscious avoidance (also known as “willful blindness” or “deliberate ignorance”).

Practical Solutions

The most straightforward solution is to abandon the rental-free business model. In a perfect scenario, a medical device firm should lease the equipment to hospitals for rent at market rate, accurately record the rent in its books and properly issue taxed invoices. If a distributor is engaged, the medical device firm should further require an undertaking by the distributor that the latter will also charge rent at market rate to hospitals. The firm may also reserve the right to audit the distributors and regularly exercise that right. These measures will minimize the risks of any rental-free arrangement between the distributor and hospitals, and even if there is such an arrangement, this solution will provide the medical device firm with a strong defense against liability.

However, this solution might be impractical in certain circumstances. High rental fees may deter hospitals from using newly developed or expensive equipment, and medical device firms may lose a strong tool to encourage or reward purchase from hospitals. Is there a way to take the cream and discard the dross of this business model?

Maybe. In fact, Chinese law does not generally prohibit discounts and rebates. Rather, the laws require only that discounts and rebates are explicitly documented in contracts and accurately recorded in the firm’s books. Therefore, one possible option is to explicitly and separately agree under the contract (1) volume-linked discounts and rebates on sales to distributors or hospitals, and (2) rental fees at market rate. Then one would adopt a properly-documented arrangement to set off the discounts/rebates and the fees. The amount of rental fees and discounts/rebates should be clearly specified in the contract and accurately recorded on every party’s respective books.

With respect to the anti-trust risks of the tie-in arrangement, it is advisable to, if technically feasible, avoid exclusive bundling arrangements and to shorten the term of the equipment loan agreement so as to provide hospitals with more flexibility in choosing alternative suppliers.

Conclusion

New business models are developed from time to time to encourage sales. These business models may carry bribery risks even if they are not readily apparent, so careful review from an anti-corruption perspective is required. Overall, transparency and accurate recordkeeping are always key to mitigating the risk of suspected corruption.


Previous Post

Latin America’s Compliance “Circle of Trust”

Next Post

Colorado High Court’s Marijuana Ruling Strengthens Employers’ Hand, Attorney Says

Wendy Wysong

Wendy Wysong

Wendy L. Wysong is a partner at Steptoe & Johnson. She served previously as a litigation partner with Clifford Chance, offering clients advice and representation on compliance and enforcement under the Foreign Corrupt Practices Act, the Arms Export Control Act, International Traffic in Arms Regulations, Export Administration Regulations, and OFAC Economic Sanctions. She was appointed by the State Department as the ITAR Special Compliance Official for Xe Services (formerly Blackwater) in 2010. Wendy combines her experience as a former federal prosecutor with the United States Attorney for the District of Columbia for 16 years with her regulatory background as the former Deputy Assistant Secretary for Export Enforcement at the Bureau of Industry and Security, U.S. Department of Commerce. She managed its enforcement program and was involved in the development and implementation of foreign policy through export controls across the administration, including the Departments of Justice, State, Treasury and Homeland Security, as well as the intelligence community. Wendy received her law degree in 1984 from the University of Virginia School of Law, where she was a member of the University of Virginia Law Review.

Related Posts

boris johnson resigns as UK prime minister

Report: Most Countries Failing to Stop Corruption

by Staff and Wire Reports
February 2, 2023

Denmark remained the least corrupt country in the world for the fifth year running, according to the recently released Transparency...

exec fired

44% of Companies Say They’ve Disciplined Execs for Ethics Breaches

by Staff and Wire Reports
February 2, 2023

More than two-fifths of companies (44%) say they have fired or disciplined senior leadership for unethical conduct in the past...

clausematch ai

Clausematch Releases Knowledge Graph to Drive Digitization of Regulation With AI

by Corporate Compliance Insights
February 2, 2023

Global RegTech provider Clausematch has released its digital knowledge graph in open source, allowing regulators and financial service companies to...

logicgate_climbchannel

LogicGate Hopes to Expand RiskCloud’s EMEA Reach

by Corporate Compliance Insights
February 2, 2023

Risk and compliance provider LogicGate is expanding its international presence thanks to a new partnership with Climb Channel Solutions, a...

Next Post
Colorado High Court’s Marijuana Ruling Strengthens Employers’ Hand, Attorney Says

Colorado High Court’s Marijuana Ruling Strengthens Employers’ Hand, Attorney Says

Compliance Job Interview Q&A

Jump to a Topic

AML Anti-Bribery Anti-Corruption Artificial Intelligence (AI) Automation Banking Board of Directors Board Risk Oversight Business Continuity Planning California Consumer Privacy Act (CCPA) Code of Conduct Communications Management Corporate Culture COVID-19 Cryptocurrency Culture of Ethics Cybercrime Cyber Risk Data Analytics Data Breach Data Governance DOJ Download Due Diligence Enterprise Risk Management (ERM) ESG FCPA Enforcement Actions Financial Crime Financial Crimes Enforcement Network (FinCEN) GDPR HIPAA Know Your Customer (KYC) Machine Learning Monitoring RegTech Reputation Risk Risk Assessment SEC Social Media Risk Supply Chain Technology Third Party Risk Management Tone at the Top Training Whistleblowing
No Result
View All Result

Privacy Policy

Founded in 2010, CCI is the web’s premier global independent news source for compliance, ethics, risk and information security. 

Got a news tip? Get in touch. Want a weekly round-up in your inbox? Sign up for free. No subscription fees, no paywalls. 

Follow Us

Browse Topics:

  • CCI Press
  • Compliance
  • Compliance Podcasts
  • Cybersecurity
  • Data Privacy
  • eBooks Published by CCI
  • Ethics
  • FCPA
  • Featured
  • Financial Services
  • Fraud
  • Governance
  • GRC Vendor News
  • HR Compliance
  • Internal Audit
  • Leadership and Career
  • On Demand Webinars
  • Opinion
  • Resource Library
  • Risk
  • Uncategorized
  • Videos
  • Webinars
  • Well-Being
  • Whitepapers

© 2022 Corporate Compliance Insights

No Result
View All Result
  • Home
  • About
    • About CCI
    • Writing for CCI
    • NEW: CCI Press – Book Publishing
    • Advertise With Us
  • Explore Topics
    • See All Articles
    • Compliance
    • Ethics
    • Risk
    • FCPA
    • Governance
    • Fraud
    • Internal Audit
    • HR Compliance
    • Cybersecurity
    • Data Privacy
    • Financial Services
    • Well-Being at Work
    • Leadership and Career
    • Opinion
  • Vendor News
  • Career Connection
  • Events
    • Calendar
    • Submit an Event
  • Library
    • Whitepapers & Reports
    • eBooks
    • CCI Press & Compliance Bookshelf
  • Podcasts
  • Videos
  • Subscribe

© 2022 Corporate Compliance Insights

Welcome to CCI. This site uses cookies. Please click OK to accept. Privacy Policy
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT